US Stock MarketDetailed Quotes

Design Therapeutics (DSGN)

Watchlist
  • 14.370
  • -0.170-1.17%
Close May 15 15:59 ET
  • 14.370
  • 0.0000.00%
Post 20:01 ET
897.51MMarket Cap-11.98P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Design Therapeutics (DSGN) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-3.49%19.71M
27.39%79.47M
8.84%18.17M
18.87%19.31M
43.38%21.57M
41.79%20.42M
-20.22%62.38M
10.40%16.69M
-13.69%16.25M
-33.43%15.04M
Selling and administrative expenses
5.67%5.33M
12.78%20.34M
4.56%4.74M
8.05%4.72M
28.80%5.83M
9.61%5.04M
-14.64%18.03M
10.42%4.54M
-21.47%4.37M
-18.17%4.53M
-General and administrative expense
5.67%5.33M
12.78%20.34M
4.56%4.74M
8.05%4.72M
28.80%5.83M
9.61%5.04M
-14.64%18.03M
10.42%4.54M
-21.47%4.37M
-18.17%4.53M
Research and development costs
-6.49%14.38M
33.32%59.13M
10.43%13.43M
22.84%14.59M
49.66%15.74M
56.89%15.38M
-22.28%44.35M
10.40%12.16M
-10.42%11.88M
-38.37%10.52M
Operating profit
3.49%-19.71M
-27.39%-79.47M
-8.84%-18.17M
-18.87%-19.31M
-43.38%-21.57M
-41.79%-20.42M
20.22%-62.38M
-10.40%-16.69M
13.69%-16.25M
33.43%-15.04M
Net non-operating interest income expense
-23.42%2.07M
-24.38%9.68M
-28.62%2.17M
-27.85%2.31M
-23.51%2.49M
2.7M
12.95%12.8M
3.04M
3.21M
3.25M
Non-operating interest income
-23.42%2.07M
-24.38%9.68M
-28.62%2.17M
-27.85%2.31M
-23.51%2.49M
--2.7M
12.95%12.8M
--3.04M
--3.21M
--3.25M
Other net income (expense)
-17.97%2.7M
5.74%3.21M
22.23%3.25M
Other non- operating income (expenses)
----
----
----
----
----
-17.97%2.7M
----
----
5.74%3.21M
22.23%3.25M
Income before tax
0.45%-17.64M
-40.74%-69.79M
-17.19%-16M
-30.36%-17M
-61.82%-19.08M
-59.52%-17.72M
25.84%-49.59M
-15.28%-13.65M
17.42%-13.04M
40.85%-11.79M
Income tax
Net income
0.45%-17.64M
-40.74%-69.79M
-17.19%-16M
-30.36%-17M
-61.82%-19.08M
-59.52%-17.72M
25.84%-49.59M
-15.28%-13.65M
17.42%-13.04M
40.85%-11.79M
Net income continuous Operations
0.45%-17.64M
-40.74%-69.79M
-17.19%-16M
-30.36%-17M
-61.82%-19.08M
-59.52%-17.72M
25.84%-49.59M
-15.28%-13.65M
17.42%-13.04M
40.85%-11.79M
Minority interest income
Net income attributable to the parent company
0.45%-17.64M
-40.74%-69.79M
-17.19%-16M
-30.36%-17M
-61.82%-19.08M
-59.52%-17.72M
25.84%-49.59M
-15.28%-13.65M
17.42%-13.04M
40.85%-11.79M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
0.45%-17.64M
-40.74%-69.79M
-17.19%-16M
-30.36%-17M
-61.82%-19.08M
-59.52%-17.72M
25.84%-49.59M
-15.28%-13.65M
17.42%-13.04M
40.85%-11.79M
Basic earnings per share
6.45%-0.29
-38.64%-1.22
-12.50%-0.27
-30.43%-0.3
-61.90%-0.34
-55.00%-0.31
26.05%-0.88
-14.29%-0.24
17.86%-0.23
41.67%-0.21
Diluted earnings per share
6.45%-0.29
-38.64%-1.22
-12.50%-0.27
-30.43%-0.3
-61.90%-0.34
-55.00%-0.31
26.05%-0.88
-14.29%-0.24
17.86%-0.23
41.67%-0.21
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -3.49%19.71M27.39%79.47M8.84%18.17M18.87%19.31M43.38%21.57M41.79%20.42M-20.22%62.38M10.40%16.69M-13.69%16.25M-33.43%15.04M
Selling and administrative expenses 5.67%5.33M12.78%20.34M4.56%4.74M8.05%4.72M28.80%5.83M9.61%5.04M-14.64%18.03M10.42%4.54M-21.47%4.37M-18.17%4.53M
-General and administrative expense 5.67%5.33M12.78%20.34M4.56%4.74M8.05%4.72M28.80%5.83M9.61%5.04M-14.64%18.03M10.42%4.54M-21.47%4.37M-18.17%4.53M
Research and development costs -6.49%14.38M33.32%59.13M10.43%13.43M22.84%14.59M49.66%15.74M56.89%15.38M-22.28%44.35M10.40%12.16M-10.42%11.88M-38.37%10.52M
Operating profit 3.49%-19.71M-27.39%-79.47M-8.84%-18.17M-18.87%-19.31M-43.38%-21.57M-41.79%-20.42M20.22%-62.38M-10.40%-16.69M13.69%-16.25M33.43%-15.04M
Net non-operating interest income expense -23.42%2.07M-24.38%9.68M-28.62%2.17M-27.85%2.31M-23.51%2.49M2.7M12.95%12.8M3.04M3.21M3.25M
Non-operating interest income -23.42%2.07M-24.38%9.68M-28.62%2.17M-27.85%2.31M-23.51%2.49M--2.7M12.95%12.8M--3.04M--3.21M--3.25M
Other net income (expense) -17.97%2.7M5.74%3.21M22.23%3.25M
Other non- operating income (expenses) ---------------------17.97%2.7M--------5.74%3.21M22.23%3.25M
Income before tax 0.45%-17.64M-40.74%-69.79M-17.19%-16M-30.36%-17M-61.82%-19.08M-59.52%-17.72M25.84%-49.59M-15.28%-13.65M17.42%-13.04M40.85%-11.79M
Income tax
Net income 0.45%-17.64M-40.74%-69.79M-17.19%-16M-30.36%-17M-61.82%-19.08M-59.52%-17.72M25.84%-49.59M-15.28%-13.65M17.42%-13.04M40.85%-11.79M
Net income continuous Operations 0.45%-17.64M-40.74%-69.79M-17.19%-16M-30.36%-17M-61.82%-19.08M-59.52%-17.72M25.84%-49.59M-15.28%-13.65M17.42%-13.04M40.85%-11.79M
Minority interest income
Net income attributable to the parent company 0.45%-17.64M-40.74%-69.79M-17.19%-16M-30.36%-17M-61.82%-19.08M-59.52%-17.72M25.84%-49.59M-15.28%-13.65M17.42%-13.04M40.85%-11.79M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 0.45%-17.64M-40.74%-69.79M-17.19%-16M-30.36%-17M-61.82%-19.08M-59.52%-17.72M25.84%-49.59M-15.28%-13.65M17.42%-13.04M40.85%-11.79M
Basic earnings per share 6.45%-0.29-38.64%-1.22-12.50%-0.27-30.43%-0.3-61.90%-0.34-55.00%-0.3126.05%-0.88-14.29%-0.2417.86%-0.2341.67%-0.21
Diluted earnings per share 6.45%-0.29-38.64%-1.22-12.50%-0.27-30.43%-0.3-61.90%-0.34-55.00%-0.3126.05%-0.88-14.29%-0.2417.86%-0.2341.67%-0.21
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +34.01%
Sample Name
Sample Code
 +27.74%
Sample Name
Sample Code
 +26.87%
4
United States Gasoline Fund Lp
UGA
+26.33%
5
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
+20.91%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +11.54%
Sample Name
Sample Code
 +10.70%
Sample Name
Sample Code
 +6.24%
4
NIO Inc
NIO
+4.27%
5
Hesai
HSAI
+3.89%
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -